Here are five key notes:
1. Analysts have a one-year price target of $21 on Surgery Partners’ shares.
2. On Nov. 15, Zacks analysts downgraded Surgery Partners’ shares from a “buy” to a “hold” rating.
3. Surgery Partners has a one-year high of $22.32 and a one-year low of $11.76.
4. The company has a 50-day moving average of $18.13 and 200-day moving average of $17.28.
5. The market cap is $835.53 million.
More articles on surgery centers:
10 largest freestanding surgery centers: SK&A
Sparrow Health unveils $20M endoscopy and radiology center: 4 things to know
KeyCorp increases Surgery Partners’ yearly EPS estimate: 5 things to know
